Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western Technology played a key role in supporting ...

Prediabetes affects a third of people in the United States and most of them will develop Type 2 diabetes, yet effective ...

In this study, researcher developed a new imaging approach that combines two powerful techniques to solve this problem. First ...

Self-labeling protein tags such as SNAP-tag offer the opportunity to attach bright and photostable synthetic fluorophores to ...

The diagnostic industry sees a surge in demand for rapid solutions, with immunoassays leading the charge. Fueled by genetic advances, multiplex assays become essential, expanding into rapid ...